• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

H1受体阻断对变应原诱导哮喘中早发和迟发性支气管收缩以及支气管反应性增加的影响。

The effect of H1-receptor blockade on the development of early- and late-phase bronchoconstriction and increased bronchial responsiveness in allergen-induced asthma.

作者信息

Twentyman O P, Ollier S, Holgate S T

机构信息

Department of Medicine I, University of Southampton, London, England.

出版信息

J Allergy Clin Immunol. 1993 Jun;91(6):1169-78. doi: 10.1016/0091-6749(93)90320-f.

DOI:10.1016/0091-6749(93)90320-f
PMID:8099592
Abstract

BACKGROUND

Allergen challenge of subjects with asthma produces an early asthmatic response, late asthmatic response, and increases bronchial responsiveness. Histamine partly mediates the early asthmatic response, and may play a role in late-phase responses. Azelastine has antiallergic properties and has been proposed as a treatment for asthma. We therefore investigated the contribution of histamine to late-phase responses with the use of the potent H1-receptor antagonist azelastine.

METHODS

Ten subjects with atopic asthma were studied in a double-blind, randomized, placebo-controlled trial. Azelastine was administered over 4 days before allergen challenge. Changes in airway caliber were followed with measurements of forced expiratory volume in 1 second, and changes in bronchial responsiveness were followed by methacholine and prostaglandin D2 bronchial provocation tests.

RESULTS

Azelastine significantly inhibited the development of the early asthmatic response. Azelastine had no effect on the late asthmatic response or on the development of allergen-induced increases in bronchial responsiveness. The power of the study was sufficient to have had a high probability of detecting any important differences between placebo and azelastine during the late phase.

CONCLUSIONS

Azelastine had no significant effect on the late-phase response model of asthma. This study does not support the hypothesis that histamine is an important mediator of the late asthmatic response or allergen-induced increases in bronchial responsiveness.

摘要

背景

对哮喘患者进行变应原激发会引发早期哮喘反应、迟发哮喘反应,并增加支气管反应性。组胺部分介导早期哮喘反应,且可能在迟发反应中起作用。氮卓斯汀具有抗过敏特性,已被提议用于治疗哮喘。因此,我们使用强效H1受体拮抗剂氮卓斯汀研究了组胺在迟发反应中的作用。

方法

在一项双盲、随机、安慰剂对照试验中对10名特应性哮喘患者进行了研究。在变应原激发前4天给予氮卓斯汀。通过测量1秒用力呼气量来跟踪气道管径的变化,通过乙酰甲胆碱和前列腺素D2支气管激发试验来跟踪支气管反应性的变化。

结果

氮卓斯汀显著抑制了早期哮喘反应的发展。氮卓斯汀对迟发哮喘反应或变应原诱导的支气管反应性增加没有影响。该研究的效能足以在后期检测到安慰剂和氮卓斯汀之间的任何重要差异。

结论

氮卓斯汀对哮喘的迟发反应模型没有显著影响。本研究不支持组胺是迟发哮喘反应或变应原诱导的支气管反应性增加的重要介质这一假设。

相似文献

1
The effect of H1-receptor blockade on the development of early- and late-phase bronchoconstriction and increased bronchial responsiveness in allergen-induced asthma.H1受体阻断对变应原诱导哮喘中早发和迟发性支气管收缩以及支气管反应性增加的影响。
J Allergy Clin Immunol. 1993 Jun;91(6):1169-78. doi: 10.1016/0091-6749(93)90320-f.
2
Effect of azelastine on the seasonal increase in non-specific bronchial responsiveness to methacholine in pollen allergic patients. A randomized, double-blind placebo-controlled, crossover study.氮卓斯汀对花粉过敏患者非特异性支气管对乙酰甲胆碱反应性季节性增加的影响。一项随机、双盲、安慰剂对照的交叉研究。
Clin Exp Allergy. 1992 Mar;22(3):371-7. doi: 10.1111/j.1365-2222.1992.tb03098.x.
3
Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma.氮卓斯汀对外源性哮喘患者组胺和白三烯C4诱导的支气管收缩的影响。
Thorax. 1988 Apr;43(4):306-11. doi: 10.1136/thx.43.4.306.
4
The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma.雾化吸入沙丁胺醇对哮喘患者吸入变应原诱发的早发和迟发哮喘反应及气道反应性增高的抑制作用。
Am Rev Respir Dis. 1991 Oct;144(4):782-7. doi: 10.1164/ajrccm/144.4.782.
5
The inhibitory actions of azelastine hydrochloride on the early and late bronchoconstrictor responses to inhaled allergen in atopic asthma.盐酸氮卓斯汀对特应性哮喘患者吸入变应原后早期和晚期支气管收缩反应的抑制作用。
J Allergy Clin Immunol. 1989 Nov;84(5 Pt 1):649-57. doi: 10.1016/0091-6749(89)90292-3.
6
A study of the clinical efficacy of azelastine in patients with extrinsic asthma, and its effect on airway responsiveness.氮卓斯汀治疗外源性哮喘患者的临床疗效及其对气道反应性的影响研究。
Br J Clin Pharmacol. 1988 Nov;26(5):515-25. doi: 10.1111/j.1365-2125.1988.tb05291.x.
7
The inhibitory effect of azelastine and ketotifen on histamine-induced bronchoconstriction in asthmatic patients.
Chest. 1987 Jun;91(6):855-8. doi: 10.1378/chest.91.6.855.
8
Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.5-脂氧合酶激活蛋白拮抗剂BAYx 1005对哮喘患者早期和晚期变应原诱导的支气管收缩的抑制作用
Thorax. 1997 Apr;52(4):348-54. doi: 10.1136/thx.52.4.348.
9
Absence of a late-phase response or increase in histamine responsiveness after bronchial provocation with adenosine 5'-monophosphate in atopic and non-atopic asthma.特应性和非特应性哮喘患者在使用5'-单磷酸腺苷进行支气管激发试验后,无迟发相反应或组胺反应性增加。
Clin Sci (Lond). 1988 Oct;75(4):429-36. doi: 10.1042/cs0750429.
10
The inhibitory effect of azelastine hydrochloride on histamine- and allergen-induced bronchoconstriction in atopic asthma.盐酸氮卓斯汀对特应性哮喘中组胺和变应原诱导的支气管收缩的抑制作用。
Clin Exp Allergy. 1989 May;19(3):315-20. doi: 10.1111/j.1365-2222.1989.tb02389.x.

引用本文的文献

1
Allergen-induced airway inflammation and its therapeutic intervention.变应原诱导的气道炎症及其治疗干预。
Allergy Asthma Immunol Res. 2009 Oct;1(1):3-9. doi: 10.4168/aair.2009.1.1.3. Epub 2009 Sep 25.
2
The effect of cetirizine and loratadine on codeine-induced histamine release in human skin in vivo assessed by cutaneous microdialysis.通过皮肤微透析评估西替利嗪和氯雷他定对体内人皮肤中可待因诱导的组胺释放的影响。
Inflamm Res. 1996 Sep;45(9):486-90. doi: 10.1007/BF02252321.
3
A double-blind, placebo controlled study of the effect of the specific histamine H1-receptor antagonist, terfenadine, in chronic severe asthma.
一项关于特异性组胺H1受体拮抗剂特非那定对慢性重度哮喘影响的双盲、安慰剂对照研究。
Br J Clin Pharmacol. 1995 Jun;39(6):671-5. doi: 10.1111/j.1365-2125.1995.tb05727.x.